<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03552055</url>
  </required_header>
  <id_info>
    <org_study_id>8000</org_study_id>
    <nct_id>NCT03552055</nct_id>
  </id_info>
  <brief_title>Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation</brief_title>
  <official_title>Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Planned Parenthood of Southeastern Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators will collect serum and urine specimens from pregnant patients along the full&#xD;
      pregnancy continuum, assay each specimen for selected placental proteins, and examine the&#xD;
      relationships between concentrations of the proteins and gestational age as determined by&#xD;
      ultrasound.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will collect serum and urine specimens from pregnant patients along with&#xD;
      ultrasound results and information about factors that may affect the concentrations of&#xD;
      proteins or the estimation of gestational age. Investigators will obtain data across the full&#xD;
      pregnancy continuum but we will over sample patients within five gestational weeks before and&#xD;
      after the 10 week mark.&#xD;
&#xD;
      Investigators will assay each specimen for selected placental proteins (Human placental&#xD;
      lactogen (HPL), Schwangerschaftsprotein 1 (SP1), Pregnancy-associated plasma protein A&#xD;
      (PAPP-A), A Disintegrin and Metalloproteinase 12 (ADAM12), and Human chorionic gonadotropin&#xD;
      (HGC)) and any other proteins of interest identified prior to running assays and will examine&#xD;
      the relationships between concentrations of the proteins and gestational age as determined by&#xD;
      ultrasound.&#xD;
&#xD;
      The goal is to identify at least one compound and a concentration threshold for that compound&#xD;
      that can be used for differentiating pregnancies of less than 10 weeks in duration from later&#xD;
      pregnancies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 24, 2017</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>protein concentration</measure>
    <time_frame>1 day</time_frame>
    <description>Concentration of placental proteins in blood and urine</description>
  </primary_outcome>
  <enrollment type="Actual">245</enrollment>
  <condition>Gestational Age</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-interventional Study</intervention_name>
    <description>no interventions in this study, just specimen collection</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      We will be collecting blood and urine specimens from participants for assay for five&#xD;
      placental proteins.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Has an intrauterine pregnancy confirmed by ultrasound&#xD;
&#xD;
          -  Not known to have pregnancy-induced hypertension (preeclampsia) or diabetes&#xD;
&#xD;
          -  Not known to have a nonviable pregnancy, a multiple pregnancy, a pregnancy with a&#xD;
             chromosomal or fetal abnormality, or a pregnancy with growth restriction&#xD;
&#xD;
          -  Not currently taking anticoagulants&#xD;
&#xD;
          -  Not currently having clinically significant vaginal bleeding, unusual pelvic pain, or&#xD;
             other symptom suggestive of a pregnancy complication&#xD;
&#xD;
          -  No use of assisted reproductive technology to conceive the current pregnancy&#xD;
&#xD;
          -  Not previously enrolled in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not meet inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Raymond</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Project</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Planned Parenthood of Southeastern Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Raymond EG, Frye LJ, Weaver MA, Lebed JP, Ren X, Steider E, Winikoff B, Barnhart KT. Sensitivity and specificity of placental proteins for gestational age screening: An exploratory study. Contraception. 2020 May;101(5):309-314. doi: 10.1016/j.contraception.2020.01.007. Epub 2020 Feb 1.</citation>
    <PMID>32014519</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>June 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2018</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>placental proteins</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

